Tolvaptan Improves Refractory Ascites and Overall Survival in Cirrhosis: A Meta-Analysis

Introduction: Refractory ascites is a frequent complication associated with liver cirrhosis. Tolvaptan, a V2-receptor antagonist, has shown effectiveness in improving refractory ascites. This meta-analysis sought to assess the effectiveness of tolvaptan in patients suffering from cirrhosis and refra...

Full description

Bibliographic Details

Published in:	Current Internal Medicine Research and Practice Surabaya Journal
Main Authors:	Chetan Kalal, Harshad Joshi, Shankar Zanwar, Madhumita Premkumar
Format:	Article
Language:	English
Published:	Faculty of Medicine, Universitas Airlangga 2025-01-01
Subjects:	cirrhosis overall survival refractory ascites tolvaptan human & health
Online Access:	https://e-journal.unair.ac.id/CIMRJ/article/view/60741